Alembic Pharmaceuticals informs about press release
Alembic Pharmaceuticals has informed that Alembic Therapeutics LLC, a step-down wholly owned subsidiary of the company, has reported its first prescription-based sale in the United States of America (US) following the commercial launch of Pivya® (pivmecillinam) tablets, an oral prescription antibiotic. The company has enclosed its press release in this regard.
The above information is a part of company’s filings submitted to BSE.
